• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Daiwa ETF TOPIX-17 Pharmaceutical

+ Add to Watchlist

1638:JP

16,330.0000 JPY 30.0000 0.18%

As of 01:32:50 ET on 10/01/2014.

Snapshot for Daiwa ETF TOPIX-17 Pharmaceutical (1638)

Open: 16,330.0000 High - Low: 16,330.0000 - 16,330.0000 Primary Exchange: Tokyo
Volume: 2 52-Week Range: 12,830.0000 - 16,640.0000 Beta vs TP17PHRM: 0.8894

ETF Chart for 1638

No chart data available.
  • 1638:JP 16,330.0000
  • 1D
  • 1M
  • 1Y
16,300.0000
Interactive 1638 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 1638

Daiwa ETF TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated i n Japan. The objective of the Fund is to provide investment results that c orrespond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 2008-07-23 Telephone: -
Managers: -
Web Site: www.daiwa-am.co.jp

Fundamentals for 1638

NAV (on 2014-09-30) 16,382.0000
Assets (M) (on 2014-09-30) 463.0000
Shares out (M) 0.03
Market Cap (M) 460.69
% Premium -0.50
Average 52-Week % Premium -0.2856
Fund Leveraged N

Dividends for 1638

Dividend Type Distribution
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-07-16) 180.0000
Dividend Yield (ttm) 2.16%

Performance for 1638

1-Month +2.58% 1-Year +24.15%
3-Month +9.96% 3-Year +21.09%
Year To Date +12.59% 5-Year +11.36%
Expense Ratio 0.18

Top Fund Holdings for 1638

Filing Date: 08/29/2014
Name Position Value % of Total
Takeda Pharmaceutical Co Ltd 20,400 96,900,000 22.307%
Astellas Pharma Inc 62,000 92,876,000 21.380%
Otsuka Holdings Co Ltd 10,800 40,845,600 9.403%
Daiichi Sankyo Co Ltd 17,100 31,429,800 7.235%
Eisai Co Ltd 6,700 29,114,850 6.702%
Ono Pharmaceutical Co Ltd 2,500 23,200,000 5.341%
Shionogi & Co Ltd 8,500 20,825,000 4.794%
Chugai Pharmaceutical Co Ltd 5,400 17,793,000 4.096%
Santen Pharmaceutical Co Ltd 2,000 12,000,000 2.762%
Taisho Pharmaceutical Holdings 1,300 10,257,000 2.361%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil